Last reviewed · How we verify
QHRD107 capsule，Venclexta and Azacitidine
At a glance
| Generic name | QHRD107 capsule，Venclexta and Azacitidine |
|---|---|
| Also known as | CDK9 inhibitors |
| Sponsor | Changzhou Qianhong Bio-pharma Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 2 |
Approved indications
Common side effects
Key clinical trials
- Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: